BRKR heads into its May 4 earnings call with short sellers rebuilding positions at pace and the Street uniformly trimming targets — a setup that leaves the stock exposed into the print.
Short interest has climbed sharply over the past month. It ran up from roughly 9.9% of the free float on April 9 to nearly 13% now — a jump of almost 3 full percentage points in under three weeks. That move is all the more striking given SI had been grinding lower through late March and early April, unwinding from a brief spike near 12.9% on March 23. The second leg higher looks more deliberate: shorts added exposure steadily every session from April 10 through April 27, with the official FINRA count putting days-to-cover at nearly 8 days. The ORTEX short score is running at 67.1, up from 64.8 just two weeks ago — a direction of travel that reflects growing bearish conviction, not just a technical squeeze.
Borrow conditions tell a different story, however. The cost to borrow is still cheap at 0.54% — effectively no premium for locating shares. Availability remains ample, meaning the lending market is not under any stress despite the rise in gross short interest. Shorts are adding here because they want to, not because a squeeze is forcing anyone out. The put/call ratio has drifted higher too, hitting 0.82 against a 20-day average of 0.76 — about one standard deviation above the mean — consistent with mild incremental hedging ahead of results rather than outright panic. Overall, positioning reads as deliberately cautious: shorts are rebuilding at scale, options traders are adding protection at the margin, and borrow is plentiful enough to keep both sides comfortable.
The Street has been moving in one direction. Analysts have been cutting targets consistently since the February earnings miss, when BRKR fell nearly 14% in a day. Barclays lowered its target to $45 from $50 in mid-April while keeping an Overweight rating. Guggenheim trimmed to $50 from $58 in late March, also holding Buy. Goldman Sachs maintains Sell with a $35 target — effectively the current price level — while Citi stays Neutral at $40. The consensus is a flat Hold with four analysts clustered there. Bulls point to constant-currency EPS growth of 5-8%, improved gross margins at 51.3%, and a forward EPS momentum rank in the 96th percentile of the universe. Bears focus on the guidance cuts: organic growth pencilled in at only 0-2%, operating margin revised flat versus a prior forecast of +140 basis points, and management flagging softer US and China conditions. Valuation multiples have eased with the stock — the P/E is at 16.4x and EV/EBITDA at 11.0x, both down modestly over the past week — but the multiple compression reflects genuine earnings uncertainty, not a clear buying signal.
Founder Frank Laukien controls 26.5% of shares outstanding and has not been active in the market recently. The notable insider pattern comes from division president Mark Munch, who has sold 2,000 shares roughly every month since at least January — a regular programme, not a one-off signal. Orbis Investment Management added 1.2 million shares in the quarter ending February, giving it a 10.6% stake and making it the second-largest external holder. Vanguard also added 785,000 shares to its 6.7% position. The institutional ownership picture looks stable rather than deteriorating.
The February print is the reference point that matters. BRKR dropped 14% on the day and a further 8.7% over the following five sessions after guiding down organic growth and cutting margin expectations. Peers have had a rough week too: TMO fell 10.4%, RGEN dropped 11.5%, and TECH shed 10.3% — so sector-wide pressure is clearly present and may limit the bounce even on a clean print.
What to watch on May 4: whether management signals any improvement in US and China order flow versus February's cautious commentary, and whether the organic growth range is revised — a third consecutive guide-down would validate the short rebuild.
See the live data behind this article on ORTEX.
Open BRKR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
